Drug
Norethindrone And Ethinyl Estradiol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Metrorrhagia | 22 | 23.3 | 23.7 | signal |
| 2 | Coeliac Disease | 12 | 22.4 | 22.6 | signal |
| 3 | Dysmenorrhoea | 13 | 18.2 | 18.4 | signal |
| 4 | Menorrhagia | 11 | 10.1 | 10.2 | signal |
| 5 | Inflammatory Bowel Disease | 5 | 9.3 | 9.3 | signal |
| 6 | Vaginal Haemorrhage | 21 | 9.0 | 9.2 | signal |
| 7 | Back Injury | 5 | 8.4 | 8.5 | signal |
| 8 | Pharyngeal Swelling | 4 | 7.6 | 7.7 | signal |
| 9 | Menstruation Irregular | 11 | 7.6 | 7.6 | signal |
| 10 | Ovarian Cyst | 4 | 7.3 | 7.3 | signal |
| 11 | Menstruation Delayed | 4 | 7.0 | 7.1 | signal |
| 12 | Bipolar Disorder | 4 | 6.7 | 6.7 | signal |
| 13 | Product Substitution Issue | 20 | 6.3 | 6.4 | signal |
| 14 | Blood Thyroid Stimulating Hormone Increased | 3 | 5.9 | 5.9 | signal |
| 15 | Amenorrhoea | 5 | 5.5 | 5.5 | signal |
| 16 | Hunger | 4 | 5.4 | 5.4 | signal |
| 17 | Pregnancy | 6 | 5.4 | 5.4 | signal |
| 18 | Breast Pain | 3 | 5.1 | 5.2 | signal |
| 19 | Exposure During Pregnancy | 16 | 4.7 | 4.8 | signal |
| 20 | Activities Of Daily Living Impaired | 5 | 4.5 | 4.6 | signal |
| 21 | Product Dispensing Error | 5 | 4.2 | 4.2 | signal |
| 22 | Product Dose Omission | 14 | 3.9 | 3.9 | signal |
| 23 | Meningioma | 3 | 3.7 | 3.7 | no signal |
| 24 | Drug Dispensing Error | 3 | 3.5 | 3.5 | no signal |
| 25 | Abortion Spontaneous | 7 | 3.2 | 3.2 | signal |
| 26 | Injection Site Bruising | 12 | 2.8 | 2.8 | signal |
| 27 | Extra Dose Administered | 6 | 2.7 | 2.8 | signal |
| 28 | Injection Site Pruritus | 10 | 2.7 | 2.8 | signal |
| 29 | Injection Site Erythema | 18 | 2.7 | 2.7 | signal |
| 30 | Multiple Sclerosis Relapse | 10 | 2.6 | 2.7 | signal |
| 31 | Multiple Sclerosis | 6 | 2.3 | 2.3 | no signal |
| 32 | Injection Site Urticaria | 3 | 2.3 | 2.3 | no signal |
| 33 | Dermatitis Atopic | 6 | 2.2 | 2.2 | no signal |
| 34 | Device Dislocation | 5 | 2.1 | 2.1 | no signal |
| 35 | Device Expulsion | 4 | 1.1 | 1.1 | no signal |